Sanofi Commits Up to $8B to Broaden Regeneron Antibody Alliance
Sanofi has committed up to $8 billion to expand its antibody-development partnership with Regeneron. The renewed agreement centers on next-generation antibody therapeutics.
Topic
Topic
Sanofi has committed up to $8 billion to expand its antibody-development partnership with Regeneron. The renewed agreement centers on next-generation antibody therapeutics.